Palatin Technologies Inc - logo

Palatin Technologies Inc - Company & Market Research Reports

Palatin Technologies is a biopharmaceutical company that develops targeted, receptor-specific peptide therapeutics for the treatment of various diseases in the United States. The company’s leading product is Bremelanotide, which is used to treat hypoactive sexual desire disorder (HSDD). It has completed pivotal Phase 3 clinical trials. Palatin also has development programs or drug candidates for inflammatory disease indications, heart failure and fibrosis. It was founded in 1986 and is based in Cranbury, New Jersey.


Global Lifestyle Drugs Market 2017-2021 - Product Thumbnail Image

Global Lifestyle Drugs Market 2017-2021

  • Report
  • 91 Pages
From
Ulcerative Colitis - Pipeline Review, H1 2018 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Review, H1 2018

  • Report
  • 482 Pages
From
Inflammatory Bowel Disease - Pipeline Review, H2 2015 - Product Thumbnail Image

Inflammatory Bowel Disease - Pipeline Review, H2 2015

  • Report
  • 1025 Pages
From
Uveitis - Pipeline Review, H1 2018 - Product Thumbnail Image

Uveitis - Pipeline Review, H1 2018

  • Report
  • 195 Pages
From
Obesity Drugs and Therapies: Technologies and Global Markets - Product Thumbnail Image

Obesity Drugs and Therapies: Technologies and Global Markets

  • Report
From
Obesity - Pipeline Review, H1 2018 - Product Thumbnail Image

Obesity - Pipeline Review, H1 2018

  • Report
  • 526 Pages
From
Obesity - Pipeline Review, H2 2017 - Product Thumbnail Image

Obesity - Pipeline Review, H2 2017

  • Report
  • 518 Pages
From
Melanocortin 4 Receptor (MC4R) Agonist -Pipeline Insight, 2018 - Product Thumbnail Image

Melanocortin 4 Receptor (MC4R) Agonist -Pipeline Insight, 2018

  • Drug Pipelines
  • 60 Pages
From
Global Sexual Dysfunction Drugs Market 2017-2021 - Product Thumbnail Image

Global Sexual Dysfunction Drugs Market 2017-2021

  • Report
  • 91 Pages
From
Female Sexual Dysfunction - Pipeline Review, H1 2018 - Product Thumbnail Image

Female Sexual Dysfunction - Pipeline Review, H1 2018

  • Report
  • 67 Pages
From
Female Hypoactive Sexual Desire Disorder - Pipeline Review, H1 2018 - Product Thumbnail Image

Female Hypoactive Sexual Desire Disorder - Pipeline Review, H1 2018

  • Report
  • 49 Pages
From
Erectile Dysfunction - Pipeline Review, H1 2018 - Product Thumbnail Image

Erectile Dysfunction - Pipeline Review, H1 2018

  • Report
  • 113 Pages
From
Female Hypoactive Sexual Desire Disorder - Pipeline Review, H2 2017 - Product Thumbnail Image

Female Hypoactive Sexual Desire Disorder - Pipeline Review, H2 2017

  • Report
  • 46 Pages
From
Erectile Dysfunction - Pipeline Review, H2 2017 - Product Thumbnail Image

Erectile Dysfunction - Pipeline Review, H2 2017

  • Report
  • 112 Pages
From
Peptide Therapeutics in Metabolic Disorders, 2016 - 2025 - Product Thumbnail Image

Peptide Therapeutics in Metabolic Disorders, 2016 - 2025

  • Report
  • 436 Pages
From
Inflammation - Pipeline Review, H1 2014 - Product Thumbnail Image

Inflammation - Pipeline Review, H1 2014

  • Report
  • 1103 Pages
From
Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2018 - Product Thumbnail Image

Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2018

  • Report
  • 420 Pages
From
Myocardial Fibrosis - Pipeline Review, H2 2017 - Product Thumbnail Image

Myocardial Fibrosis - Pipeline Review, H2 2017

  • Report
  • 85 Pages
From
Drug Delivery Systems: US Market Outlook, Advances for Pharma, Biotech & Medical Devices - Product Thumbnail Image

Drug Delivery Systems: US Market Outlook, Advances for Pharma, Biotech & Medical Devices

  • Report
  • 163 Pages
From
Fibrosis - Pipeline Review, H2 2017 - Product Thumbnail Image

Fibrosis - Pipeline Review, H2 2017

  • Report
  • 122 Pages
From
Loading Indicator
adroll